1 min read
Johnson & Johnson Discusses Ollin Biosciences Deal Worth Up to $3.4B
An announcement could come as soon as Monday, Nov. 16.

Johnson & Johnson is in talks to acquire privately held Ollin Biosciences for up to $3.4 billion. An announcement could come as soon as Monday, Nov. 16.
The talks concern a potential purchase; no completed acquisition is announced.